By Faith Patenaude, Investor Research Analyst, LSN
The benefit of attending RESI Europe is not only due to the partnering and networking, but also the chance to learn from active investors on a variety of panel topics featured throughout the conference. Taking place in person June 17th and virtually June 18th – 19th, RESI Europe will feature a dynamic range of panels covering topics such as Oncology Innovation, Early-Stage Therapeutics, Cross Boarder Investments, and more!
We are excited to present our Seed Funds panel, taking place at 9:00AM June 17th, featuring 6 accomplished and seasoned investors. These experts, all from firms specializing in early-stage investments, will share their knowledge on key topics such as the level of proof-of-concept validation required for seed funding and the significant roles investors play in the early stages of companies. Additionally, they will discuss strategies on how to balance the high risks of early investments with the potential for increased returns. The panel will feature the below investors:
RESI Europe Seed Fund Panel Speakers |
||
 Farzad Abdi-Dezfuli Partner Sarsia |
 Jorge Blasco Venture Partner (Spain) Lumo Labs |
 Emma Gasol Investment Director AdBio partners |
 Soyoung Park Venture Partner (US & Europe) VU Venture Partners |
 Sara Secall Partner Inveready Asset Management |
 Jaromir Zahrádka CEO & Managing Partner, i&i Biotech Fund i&i Bio |
By attending RESI Europe, you will have the opportunity to not only foster meaningful connections but gain valuable knowledge to support your fundraising efforts.
Don’t miss out on this incredible opportunity to learn from top investors and network with industry leaders. Join us in person on June 17th or virtually on June 18th and 19th. We look forward to seeing you at what promises to be another exceptional conference.
Next Phase Newsletter 
Leave a comment